Vanderbilt-Ingram Cancer Center

Vanderbilt-Ingram website >

(iStock)
May 14, 2024

Breast cancer risk variants identified for women of African ancestry

A study led by researchers from Vanderbilt-Ingram Cancer Center sheds light on some of the genetic variants that make breast cancer more deadly for women of African ancestry and significantly reduces the disparity in knowledge for assessing their genomic risk factors.

By Tom Wilemon
May 7, 2024

Study seeks to evaluate military exposures on veterans’ lung cancer risk 

A prospective cohort of veterans including those with military toxic exposures, such as burn pits, will be screened annually with low-dose chest CT to detect lung cancer and other disease early.

By Tom Wilemon
Screenshot of the newly launched news.vumc.org. The homepages features a photo of a 'Donate Life' event and highlights the design of VUMC News.
May 3, 2024

Enhanced ‘VUMC News’ website offers new features

The new site is designed to provide easier access to information for members of the VUMC community, and for millions of other visitors to the site each year.

By Holly Fletcher
(photo by Erin O. Smith)
May 2, 2024

25th Annual VICC Scientific Retreat focuses on hereditary cancers

The Vanderbilt-Ingram Cancer Center 25th Annual Scientific Retreat will focus on hereditary cancers and feature nationally and internationally renowned speakers on the subject.

By Tom Wilemon
Jeff Balser, MD, PhD, spoke about the Medical Center’s growth during the Spring Leadership Assembly. (photo by Erin O. Smith)
May 2, 2024

VUMC Growth Strengthens Communities

Recent expansions in locations, capacity and business lines underscore how VUMC is navigating fast-paced population growth and the financial headwinds facing health systems across the country.

By Holly Fletcher
(photo by Erin O. Smith)
April 25, 2024

Making a splash for cancer research

The third annual Swim Across America – Nashville was held April 21 at Ensworth Natatorium on the Ensworth School’s Frist Campus. The event raises funds for research at Vanderbilt-Ingram Cancer Center.

April 24, 2024

VUMC hosts symposium on stem cell transplants and cellular therapies

The Vanderbilt Stem Cell Transplant and Cellular Therapy Symposium offers clinicians detailed information on the latest developments for hematological diseases, ranging from immunotherapies for blood cancers to new, curative therapies for sickle cell disease.
By Tom Wilemon
April 11, 2024

Cathy Eng to participate in April 15 congressional briefing

Cathy Eng, MD, will participate in a congressional briefing on April 15 focused on “Addressing Representation in Clinical Trials.”
By Tom Wilemon
April 8, 2024

Chris Williams named VICC director for Research Education

Chris Williams, MD, PhD, associate dean for Physician-Scientist Education and Training at Vanderbilt University, has been named to lead Research Education at Vanderbilt-Ingram Cancer Center.
By Tom Wilemon
April 8, 2024

Karen Winkfield named VICC director for Community Outreach and Engagement

Karen Winkfield, MD, PhD, Ingram Professor of Cancer Research, has been named associate director for Community Outreach and Engagement at Vanderbilt-Ingram Cancer Center.
By Tom Wilemon
April 5, 2024

Eunyoung Choi’s gastric cancer research merits AACR-Debbie’s Dream funding

Ongoing research by Eunyoung Choi, PhD, into how cells transform into abnormal versions of themselves that are the precursors to stomach cancer has received support from the American Association for Cancer Research.
By Tom Wilemon
April 3, 2024

Excess salt linked to heart disease deaths in low-income group: study

Excessive consumption of dietary sodium likely was responsible for up to 30% of cardiovascular disease-related deaths among mostly low-income participants in a large cohort study conducted by Vanderbilt University Medical Center.
By Bill Snyder
March 28, 2024

Study identifies molecule as potential target for treating AML

While immune checkpoint inhibitors that target the PD-1 molecule on T-cells have proven to be effective with many cancers, these immunotherapies have not worked for acute myeloid leukemia (AML), but new research has identified a “cousin” molecule as a potential therapeutic target for AML. 
By Tom Wilemon